Qui Tam 101
Guess What Else is NOT a Top Priority of the FDA?
Answer: Monitoring postmarketing study commitments.
The FDA lacks an effective system for monitoring postmarketing study commitments. See the latest OIG Report, dated June 2006.
No Tags| Posted By Kenneth Nolan | |
| Category Legal | Posted July 12th, 2006 |
| Bookmark | |
Leave a Reply
Articles & Quotes
- Pages
- Categories
- False Claims Act (13)
- Health care (7)
- Legal (42)
- Medicare (4)
- Off-Label (1)
- Feeds
- Archives
Nolan & Auerbach, P.A. is a qui tam law firm whose practice is uniquely limited to healthcare fraud cases under the qui tam provisions of the False Claims Act. We know healthcare fraud because that's what we do! Toll free: 800-FRAUD 04
"The hiring of a lawyer is an important decision that should not be based
solely on advertisements. Before you decide, ask us to send you free written
information about our qualifications and experience."
Licensed in Florida
Located in Fort Lauderdale, Florida
Available for National Cases